2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow JTK-853: new trials by email Literature Review of JTK-853 trials Research Report on JTK-853
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects JTK-853, Dose 2 JTK-853, Dose 3 JTK-853 - Hepatitis C Virus Infection, Response to Therapy of | Phase 1 | Completed | Akros Pharma Inc. | 29 | 2010-08-01 | 2011-11-21 |
| Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects JTK-853, ketoconazole, JTK-853 or Placebo - Healthy | Phase 1 | Terminated | Akros Pharma Inc. | 41 | 2010-03-01 | 2011-11-21 |
| Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects JTK-853 or Placebo - Healthy | Phase 1 | Completed | Akros Pharma Inc. | 70 | 2010-01-01 | 2011-11-22 |
Hepatitis C (1)
United States (2) · Puerto Rico (1)